| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
|
Li, Wang
|
|
|
10 |
12 |
p. 840-841
|
article
|
| 2 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes
|
Kjeldsen, Sverre E
|
|
|
10 |
12 |
p. 840
|
article
|
| 3 |
Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes – Authors' reply
|
Nazarzadeh, Milad
|
|
|
10 |
12 |
p. 841-842
|
article
|
| 4 |
COP27 Climate Change Conference: urgent action needed for Africa and the world
|
Atwoli, Lukoye
|
|
|
10 |
12 |
p. 837-839
|
article
|
| 5 |
Diabetes education: the key to a brighter tomorrow
|
The Lancet Diabetes & Endocrinology,
|
|
|
10 |
12 |
p. 827
|
article
|
| 6 |
Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
|
Inzucchi, Silvio E
|
|
|
10 |
12 |
p. 869-881
|
article
|
| 7 |
Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alström syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period
|
Haqq, Andrea M
|
|
|
10 |
12 |
p. 859-868
|
article
|
| 8 |
Estimating the total incidence of type 1 diabetes in children and adolescents aged 0–19 years from 1990 to 2050: a global simulation-based analysis
|
Ward, Zachary J
|
|
|
10 |
12 |
p. 848-858
|
article
|
| 9 |
Gestational diabetes in Australia: navigating a tsunami
|
McIntyre, H David
|
|
|
10 |
12 |
p. 846-847
|
article
|
| 10 |
Glucose-lowering drugs with cardiovascular benefits as modifiers of critical elements of the human life history
|
Avogaro, Angelo
|
|
|
10 |
12 |
p. 882-889
|
article
|
| 11 |
Lorenz Hofbauer: connecting the unexpected
|
Burki, Talha
|
|
|
10 |
12 |
p. 844
|
article
|
| 12 |
Open-source automated insulin delivery in type 1 diabetes—the evidence is out there
|
Hussain, Sufyan
|
|
|
10 |
12 |
p. 835-836
|
article
|
| 13 |
Prequalification of insulin: what is missing?
|
Beran, David
|
|
|
10 |
12 |
p. 842-843
|
article
|
| 14 |
Reduction in heart failure outcomes with SGLT2 inhibitors irrespective of glycaemic status
|
Gerstein, Hertzel C
|
|
|
10 |
12 |
p. 831-832
|
article
|
| 15 |
Setmelanotide for controlling weight and hunger in Bardet-Biedl syndrome
|
Tauber, Maithe
|
|
|
10 |
12 |
p. 829-830
|
article
|
| 16 |
Social media and misinformation in diabetes and obesity
|
Burki, Talha
|
|
|
10 |
12 |
p. 845
|
article
|
| 17 |
The 2022 hormone therapy position statement of The North American Menopause Society: no news is good news
|
Nappi, Rossella E
|
|
|
10 |
12 |
p. 832-834
|
article
|
| 18 |
The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery
|
Khunti, Kamlesh
|
|
|
10 |
12 |
p. 890-900
|
article
|
| 19 |
Trending now: modelling global epidemiology of type 1 diabetes in children and adolescents
|
Stene, Lars C
|
|
|
10 |
12 |
p. 828-829
|
article
|
Journal description